Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reaction
Rituximab treatment can accelerate hepatitis C virus replication
July 14th, 2006
A study from Turkey has reported that hepatitis C virus (HCV) replication is accelerated during rituximab treatment in non-Hodgkin lymphoma (NHL). "The treatment of patients with NHL may be complicated by concomitant chronic HCV infection. Recent data suggest that HCV may also be a contributing factor to the development of this disease. "Although antiviral treatment has occasionally been reported to result in the regression of lymphoma in patients with HCV infection, the importance of the control of this infection on the prognosis of lymphoma needs to be defined," wrote S. Aksoy and colleagues, Hacettepe University. "Here we...
Source: Genomics & Genetics Weekly (2006-07-14)
|
